Jonathan Beilan, M.D.

Board Certified Board Certified

  • Urology
Patient Testimonial
Dr. Libby was just amazing. We had a long journey and she was right there with us in the trenches. She was our third fertility doctor. She thought outside the box, was willing to try new things, was open to our questions, and used her team to help us.

I went through IVF with Dr. Humm. I felt heard, comforted, and comfortable the whole way. The support staff were beyond fantastic and turned what would have been a scary experience, into something that my husband and I never felt like we were navigating alone.

Dr. Libby listened to our every concern and communicated with us when we needed it, never making us feel pushed to the side or that she was to busy to be there for us.

From the first consultation until our final appointment Dr. Doyle was empathetic, compassionate, and very easy to talk to. He reviewed my diagnosis and treatments each step of the way and changed our protocols accordingly to result in a positive and viable pregnancy.

I had an ultrasound and an HSG done at the Norfolk office. Every staff member was amazing – so gentle, comforting and supportive. I’m very grateful for that.

Dr. Banks is attentive, kind, and professional. She answered all of our questions.

Biography

Shady Grove Fertility Tampa Bay is proud to partner with University of South Florida board certified reproductive urologist, Jonathan Beilan, M.D. Now, SGF Tampa Bay patients will have even more convenient, integrated fertility care to address and treat male factor infertility.

Dr. Jonathan Beilan is a highly trained board-certified urologist working at Advanced Urology Institute in Largo, FL. Dr. Beilan completed his Male Reproductive Medicine and Microsurgery Fellowship with Dr. Lipshultz in Houston, Texas in 2019.

Dr. Jonathan Beilan was born and raised on the Gulf Coast of Florida in New Port Richey. He received his undergraduate degree in Molecular Biology and Microbiology from the University of Central Florida. In 2009, he was selected to be part of the UCF College of Medicine’s inaugural class in Orlando, Florida. Dr. Beilan completed his general surgery internship and urologic residency at the University of South Florida in Tampa, Florida. Under Dr. Carrion’s mentorship, Dr. Beilan became well-versed with complex male prosthetic surgical cases as well as the management of Peyronie’s disease. He then completed his clinical fellowship at Baylor College of Medicine in 2018-2019. Here, Dr. Beilan learned the complexities of male fertility treatments and the intricacies of microsurgical procedures such as varicocele repairs and vasectomy reversals.

Dr. Beilan now specializes in erectile dysfunction and other sexual problems such as Peyronie’s disease and low testosterone, as well as infertility and the microsurgical procedures involved in assisting males father biologic children. With offices in Largo and Palm Harbor, FL, Dr. Beilan serves the greater Tampa Bay community with regard to ED, male fertility, sexual medicine, and men’s health issues. He is an active member within the AUI/Solaris family and remains committed to patient and trainee education.

In 2022, Dr. Beilan was appointed as an Assistant Professor to the Collaborative Faculty of the USF Department of Urology, and currently hosts USF REI fellows as part of their male reproductive medicine rotation. Dr. Beilan is also a member of of the Sexual Medicine Society of North America (SMSNA), American Urological Association (AUA) and its Southeastern Section (SESAUA), the American Society for Reproductive Medicine (ASRM), and the Society for Male Reproduction and Urology (SMRU).

In his spare time, Dr. Beilan enjoys playing soccer and ultimate frisbee, traveling, and spending time with his wife, Ashley, and two children.

Education

  • Residency: Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
  • Fellowship: Reproductive Endocrinology & Infertility, University of California, San Francisco, California 
  • Fertility and Sterility, associate and specialty editor  
  • Excellent Contribution from American Journal of Obstetrics and Gynecology  
  • Excellent Contribution from Human Reproduction  
  • American Society for Reproductive Medicine (ASRM) 
  • Society of Assisted Reproduction Technologies (SART) 
  • Meernik C, Mersereau JE, Baggett CD, Engel SM, Moy LM, Cannizzaro NT, Peavey M, Kushi LH, Chao CR, Nichols HB.  Fertility Preservation and Financial Hardship among Adolescent and Young Adult Women with Cancer.  Cancer Epidmiol Biomarkers Prev.  2022 May 4;31(5):1043-51. 
  • Meernik C, Engel SM, Wardell A, Baggett CD, Gupta P, Rodriguez-Ormaza N, Luke B, Baker VL, Wantman E, Rauh-Hain JA, Mersereau JE, Olshan AF, Smitherman AB, Cai J, Nichols HB.  Disparities in fertility preservation use among adolescent and young adult women with cancer.  J Cancer Surviv. 2022 Feb 16. doi: 10.1007/s11764-022-01187-y. Online ahead of print.   
  • Legro RS, Hansen KR, Diamond MP, Steiner AZ, Coutifaris C, Cedars MI, Hoeger KM, Usadi R, Johnstone EB, Haisenleder DJ, Wild RA, Barnhart KT, Mersereau J, Trussell JC, Krawetz SA, Kris-Etherton PM, Sarwer DB, Santoro N, Eisenberg E, Huang H, Zhang H; Reproductive Medicine Network. Effects of preconception lifestyle intervention in infertile women with obesity: The FIT-PLESE randomized controlled trial. PLoS Med. 2022 Jan 18;19(1). 
  • Giunco H, Connerney M, Boylan C, Koelper N, Mersereau J, Berger DS. Embryo re-expansion does not affect clinical pregnancy rates in frozen embryo transfer cycles: a retrospective study. J Assist Reprod Genet. 2021 Nov;38(11):2933-2939. Epub 2021 Sep 21. 
  • Hawkins Bressler L, Mersereau JE. Not throwing away my shot but taking less: three-arm randomized controlled trial finds equivalent live birth rate with intramuscular progesterone every third day for programmed frozen embryo transfer cycles. Fertil Steril. 2021 Sep;116(3):655-656. Epub 2021 Jul 28.   
  • Nichols HB, Baggett CD, Engel SM, Getahun D, Anderson C, Cannizzaro NT, Green L, Gupta P, Laurent CA, Lin PC, Meernik C, Moy LM, Wantman E, Xu L, Kwan ML, Mersereau JE^, Chao CR, Kushi LH.  The Adolescent and Young Adult (AYA) Horizon Study: An AYA Cancer Survivorship Cohort.  Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):857-866. Epub 2021 Feb 22. 
  • Moustafa SM, Rosen E, Boylan C, Mersereau JE#.  Time to blastulation is superior to individual components of embryo grading for live-birth prediction. Fertil Steril Rep Vol (3), Oct 2020 243-8. 
  • Stanhiser J, Mersereau JE^, Dock D, Boylan C, Caprell H, Coward RM, Berger DS, Fritz M.  Sperm morphology from the actual inseminated sample does not predict clinical pregnancy following intrauterine insemination. Fertil Steril Rep. Vol. 2, No. 1, March 2021 2666-3341.   
  • Hawkins Bressler L, Mersereau JE^, Anderson C, Rodriguez JL, Hodgson E, Weinberg CR, Sandler DP.  Fertility-related experiences after breast cancer diagnosis in the NIEHS Sister Study and Two Sister Study Survivor Survey.  Cancer. 2019 Apr 23 [Epub ahead of print]. 
  • Gorman JR, Drizin JH, Mersereau JE^, Su HI.  Applying behavioral theory to understand fertility consultation uptake.  Psycho-Oncology. 2019 Feb 14 [Epub ahead of print].   
  • Eisenberg A, Mersereau JE^, Buckley AF, Gratian L.  Multiple pituitary adenoma with functional FSH secretion leading to ovarian hyperstimulation syndrome.  Accepted to AACE Clinical Case Reports 10/18. (14 typed pages) 
  • Smith BM, et al.^ The National Physicians Cooperative: transforming fertility management in the cancer setting and beyond.  Future Oncology. 2018 Nov 26 [Epub ahead of print].   
  • Nichols HB, Anderson C, Ruddy KJ, Black KZ, Luke B, Engel SM, Mersereau JE^. Childbirth after adolescent and young adult cancer: A population-based study.  J Cancer Surviv.  2018 Aug;19(4):592-600.  2018 May 22 [Epub ahead of print].  (8 pages) 
  • Stieglitz HM, Korpi-Steiner N, Katzmann B, Mersereau JE^, Styner M. Suspected testosterone-producing tumor in a patient taking biotin supplements.  J Endocrine Society.  2018 May 10;2(6);563-569. (6 pages) 
  • Schumacher BML, Mersereau JE^, Steiner AZ.  Cycle day, estrogen level, and lead follicle size: analysis of 27,790 in vitro fertilization cycles to determine optimal start criteria for gonadotropin-releasing hormone antagonist.  Fertil Steril. 2018 Apr;109(4);633-637.  2018 Mar 28 [Epub ahead of print].  (4 pages) 
  • Hoff HS, Crawford NM, Mersereau JE^.  Screening for psychological conditions in infertile women: Provider perspectives. J Womens Health (Larchmt). 2018 Apr;27(4);503-509. 2017 Nov 29. [Epub ahead of print].  (6 pages) 
  • Cameron KE, Kole MB, Sammel MD, Ginsberg JP, Gosiengfiao Y, Mersereau JE#, Su HI, Gracia CR. Acute menopausal symptoms in young cancer survivors immediately following chemotherapy.  Oncology. 2018;94(4);200-206.  2018 Jan 26. [Epub ahead of print]. (6 pages) 
  • Mersereau J*, Stanhiser J, Coddington C, Jones T, Luke B, Brown MB.  Patient and cycle characteristics predicting high pregnancy rates with single embryo transfer: an analysis of the SART outcomes between 2004-2013.  Fertility and Sterility. Fertil Steril. 2017 Nov;108(5):750-756. Epub 2017 Sep 15. (6 pages) 
  • Lyttle Schumacher B, Grover N, Mesen T, Steiner A, Mersereau J#.  Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.  Hum Reprod. 2017 Oct 1;32(10):2049-2055. (6 pages) 
  • Anderson C, Engel SM, Mersereau JE^, Black KZ, Wood WA, Anders CK, Nichols HB.  Birth outcomes among adolescent and young adult cancer survivors.  JAMA Oncol. 2017 Aug:3(8);1078-84. [Epub ahead of print 2017 Mar 23]  (6 pages)  
  • Crawford NM, Hoff HS, Mersereau JE#.  Infertile women who screen positive for depression are less likely to initiate fertility treatments.  Hum Reprod. 2017 Mar 1;32(3);582-7.  2017 Jan 9 [Epub ahead of print].  (5 pages) 

Q&A

I became an REI physician for several reasons: I am passionate about women’s health, from pap smears to IVF. I find the science behind reproductive medicine fascinating – there have been major advances in pregnancy rates in the nearly 20 years I’ve been in practice. Most importantly, I enjoy getting to know my patients and love sharing laughs and hugs every day! 

I appreciate that SGF aims to take a complicated and potentially stressful process and make it as easy and straightforward for patients as possible. This is evident in their high pregnancy rates, their compassionate staff, their Shared Risk 100% Refund program, and the easy access to care. They also actively initiate high-quality research projects, moving the field of REI forward to improved outcomes for patients.    

I find so many patients inspiring! It takes a lot of courage to even start down the fertility journey, and I’m constantly honored to have patients put their faith and trust in me to guide them on their path to achieve their family goals.   

I try to work with my patients to identify the root of the struggle – it’s a different solution based on the exact problem. I often enlist input from my whole team – between the nursing team, financial counselors, mental health providers, nutritionists, and others, we generally can work together with our patients to overcome most struggles. 

I’d love to live in a foreign country someday, for at least part of the year. 

I play a lot of doubles tennis – I can turn off external stresses for a brief time and have fun while exercising! I also love reading, mostly fiction – it’s fun when patients and I share book suggestions. 

I tend to always be ‘on the go’, running errands, trying a new restaurant, etc. I sometimes wish I could take more naps, but it’s not in my DNA. 

Public events & seminars

View All Events